Case Report: Infection With SARS-CoV-2 in the Presence of High Levels of Vaccine-Induced Neutralizing Antibody Responses.

SARS-CoV-2 breakthrough infection mRNA vaccines neutralizing antibodies virus variants

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2021
Historique:
received: 03 05 2021
accepted: 29 06 2021
entrez: 9 8 2021
pubmed: 10 8 2021
medline: 10 8 2021
Statut: epublish

Résumé

We present a case of SARS-CoV-2 B.1. 525 infection in a healthcare worker despite the presence of highly neutralizing, multivariant-specific antibodies 7 weeks after full vaccination with the mRNA vaccine BNT162b2. We show that the virus replicated to high levels in the upper respiratory tract over the course of several days in the presence of strong antibody responses. The virus was readily propagatable

Identifiants

pubmed: 34368197
doi: 10.3389/fmed.2021.704719
pmc: PMC8342944
doi:

Types de publication

Case Reports

Langues

eng

Pagination

704719

Informations de copyright

Copyright © 2021 Schulte, Marx, Korencak, Emmert, Aldabbagh, Eis-Hübinger and Streeck.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cell Rep. 2021 Jan 26;34(4):108666
pubmed: 33503420
N Engl J Med. 2021 Jun 10;384(23):2212-2218
pubmed: 33882219
PLoS One. 2020 Nov 17;15(11):e0242537
pubmed: 33201914
Nat Immunol. 2013 May;14(5):428-36
pubmed: 23598398
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Clin Infect Dis. 2021 Jun 17;:
pubmed: 34137815
Nat Med. 2021 May;27(5):790-792
pubmed: 33782619
Lancet. 2021 Apr 10;397(10282):1351-1362
pubmed: 33798499
N Engl J Med. 2021 Apr 15;384(15):1412-1423
pubmed: 33626250
Aging Dis. 2011 Oct;2(5):374-81
pubmed: 22396889
Emerg Microbes Infect. 2021 Dec;10(1):1241-1243
pubmed: 34092181
Nat Commun. 2020 Nov 17;11(1):5829
pubmed: 33203887

Auteurs

Bianca Schulte (B)

Institute for Virology, University Hospital Bonn, Bonn, Germany.

Benjamin Marx (B)

Institute for Virology, University Hospital Bonn, Bonn, Germany.

Marek Korencak (M)

Institute for Virology, University Hospital Bonn, Bonn, Germany.

Dorian Emmert (D)

Institute for Virology, University Hospital Bonn, Bonn, Germany.

Souhaib Aldabbagh (S)

Institute for Virology, University Hospital Bonn, Bonn, Germany.

Anna Maria Eis-Hübinger (AM)

Institute for Virology, University Hospital Bonn, Bonn, Germany.

Hendrik Streeck (H)

Institute for Virology, University Hospital Bonn, Bonn, Germany.

Classifications MeSH